Metraipolis › archive › dc_881472ca1e8a
GLP-1 agonist, semaglutide use in acute pulmonary embolism recovery: a four-week proof-of-concept study including proteomic profiling — Europe PMC PMID:41536961
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41536961
- DOI
- 10.1093/ehjopen/oeaf170
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T10:24:26.392Z
- SHA-256 of the archived text
46a2d0334a8174a559c92acf510b0ade3f48f3f55338771f7935bc279a083334- Stable URL of this page
https://metraipolis.com/documento/dc_881472ca1e8a
How to cite
GLP-1 agonist, semaglutide use in acute pulmonary embolism recovery: a four-week proof-of-concept study including proteomic profiling — Europe PMC PMID:41536961 — Europe PMC (en), https://europepmc.org/article/MED/41536961 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_881472ca1e8a (Metraipolis archive dc_881472ca1e8a, sha256 46a2d0334a8174a559c92acf510b0ade3f48f3f55338771f7935bc279a083334)
BibTeX
@misc{dc881472ca1e8a,
title = {GLP-1 agonist, semaglutide use in acute pulmonary embolism recovery: a four-week proof-of-concept study including proteomic profiling — Europe PMC PMID:41536961},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41536961},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_881472ca1e8a; sha256 46a2d0334a8174a559c92acf510b0ade3f48f3f55338771f7935bc279a083334},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41536961. Agents can read the archived copy with the MCP tool read_document.